Literature DB >> 29990995

Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.

Sayed-Hamidreza Mozhgani1,2, Hamid Reza Jahantigh3,4, Houshang Rafatpanah1, Narges Valizadeh1, Asadollah Mohammadi1, Samira Basharkhah1, Seyed Abdolrahim Rezaee1.   

Abstract

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neuroinflammatory disease related to human T lymphotropic virus type 1 (HTLV-1) infection. Interferon type III (IFN-λ), which includes IL28, IL29, and IL28R, and affects the outcome of viral infections, might be complicated in the progression of HAM/TSP. Here, we investigated the host-virus interactions in the manifestation of HAM/TSP, using IL28B, IL29, IL28R, HTLV-1 Tax, HTLV-1 basic leucine zipper factor (HBZ), and proviral load (PVL). The study groups consisted of 20 patients with HAM/TSP, 20 asymptomatic HTLV-1 carriers (ACs), and 20 healthy controls (HCs). The means of PVL, Tax, and HBZ gene expressions in the HAM/TSP group (p = 0.004, 0.006, and < 0.0001, respectively) were significantly higher than in the AC group. The comparison of IL28B, IL29, and IL28R expression in the HAM/TSP, AC, and HC groups revealed no significant difference between the first 2, but lower concentrations in the HCs (IL28B: p = 0.03, 0.01; IL29: p = 0.07, 0.01; and IL28R: p < 0.0001, respectively). In the HAM/TSP group, correlations were seen between Tax and HBZ (R = 0.61, p = 0.004) and between Tax and IL29 (R = 0.45, p = 0.04). Negative correlations were observed between Tax and IL28B (R = -0.49, p = 0.02) and between HBZ and IL28R (R = -0.43, p = 0.06). In the ACs, an inverse correlation was found between Tax and IL28B (R = -0.42, p = 0.06). These findings suggest that IL29, IL28B, and IL28R interfere in the infection of HAM/TSP, mainly via Tax activation.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  HTLV-1-associated myelopathy/tropical spastic paraparesis; Human T lymphotropic virus type 1; Interferon lambda

Mesh:

Substances:

Year:  2018        PMID: 29990995     DOI: 10.1159/000490058

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  7 in total

1.  HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules.

Authors:  Asadollah Mohammadi; Bahare Fazeli; Zohreh Poursina; Farahnaz Tehranian; Veda Vakili; Reza Boostani; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2019-07-18       Impact factor: 3.402

2.  A significant association between CXCL10 -1447 A > G and IL18 -607 C > A gene polymorphism with human T-cell lymphotropic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM-TSP), a case-control report from city of Mashhad, Iran.

Authors:  Houshang Rafatpanah; Zohreh Poursina; Reza Boostani; Hadi Zare Marzouni; Mahdi Atabaki; Reza Farid Hosseini; Jalil Tavakkol-Afshari; Mojgan Mohammadi
Journal:  J Neurovirol       Date:  2021-03-02       Impact factor: 2.643

3.  Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis.

Authors:  Mohadeseh Zarei Ghobadi; Sayed-Hamidreza Mozhgani; Yousef Erfani
Journal:  J Neurovirol       Date:  2021-01-06       Impact factor: 2.643

Review 4.  Nanotechnology based strategies for HIV-1 and HTLV-1 retroviruses gene detection.

Authors:  Sayed-Hamidreza Mozhgani; Hanie Ahmadzade Kermani; Mehdi Norouzi; Mohsen Arabi; Saber Soltani
Journal:  Heliyon       Date:  2020-05-27

5.  Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.

Authors:  Shahrzad Shadabi; Nargess Delrish; Mehdi Norouzi; Maryam Ehteshami; Fariba Habibian-Sezavar; Samira Pourrezaei; Mobina Madihi; Mohammadreza Ostadali; Foruhar Akhgar; Ali Shayeghpour; Cobra Razavi Pashabayg; Sepehr Aghajanian; Sayed-Hamidreza Mozhgani; Seyed-Mohammad Jazayeri
Journal:  Infect Agent Cancer       Date:  2021-06-29       Impact factor: 2.965

Review 6.  Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.

Authors:  Antonio Carlos Rosário Vallinoto; Izaura Cayres-Vallinoto; Maria Alice Freitas Queiroz; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2019-10-23       Impact factor: 5.048

7.  An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.

Authors:  Sayed-Hamidreza Mozhgani; Mehran Piran; Mohadeseh Zarei-Ghobadi; Mohieddin Jafari; Seyed-Mohammad Jazayeri; Talat Mokhtari-Azad; Majid Teymoori-Rad; Narges Valizadeh; Hamid Farajifard; Mehdi Mirzaie; Azam Khamseh; Houshang Rafatpanah; Seyed-Abdolrahim Rezaee; Mehdi Norouzi
Journal:  Retrovirology       Date:  2019-12-30       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.